Artificial intelligence (AI) is becoming embedded into the fabric of quality, compliance, and production systems and shaping how teams interact with software, how processes are managed, and how work ...

From affordability to sustainability — how economic shifts, technology, and culture are driving the resurgence of the ...

Gilead Sciences Inc (NASDAQ:GILD) stock is up 5.7%, hitting a record high of $155.56 at last glance, after the biopharmaceutical company announced a top- and bottom-line win for the fourth quarter.

Artificial intelligence is no longer a promise of the future in the life sciences. It is quickly becoming a core competency for launching, scaling, and sustaining therapies. As the volume of data ...

Two major London life sciences schemes progressed this week as the sector recovers from a slow few years. A £500M mixed-use scheme involving a major life sciences component near King’s Cross was ...

Chiba, Japan, January 12, 2026—A team at Japan’s National Institutes for Quantum Science and Technology (QST) has published a field-defining Perspective that places the societal payoff of quantum ...

Power Moves is a recurring series where we chart the comings and goings of talent across the region. Got a new hire, gig or promotion? Email us at philly@technical.ly. Philly companies and ...

Daniel is a News Writer from the United Kingdom. Relatively new to the industry with just over three years of experience, he has focused on establishing himself in the gaming space, with bylines in ...

Research shows that women remain woefully underrepresented at the highest levels of leadership in the life sciences industry. Those who have broken through that glass ceiling, however, are not only ...

Taylor Gray wears Novocure’s Optune Gio while recounting his experience during the treatment of his glioblastoma during the NHLS Live Free Life Science 2025 event, at The Artisan at Tuscan Village, in ...

This strategic move will enable Crown Bioscience to operate as a standalone entity under Adicon's ownership. Crown Bioscience's comprehensive portfolio of translational oncology services, including ...

AMERICA’s BODY corporate looks, as a whole, to be in rude health. One large company after another is presenting record quarterly results. Bosses are raising profit forecasts left and right. Poke and ...